Evidence map›Paper›PMID 35530386›Full record

ArticleRSC advances2022

Janus transition metal dichalcogenides in combination with MoS

Birhan Tesfaye Beshir, Kingsley O Obodo, Georgies A Asres

Abstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Two-dimensional MXO/MoXRSC advances · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Birhan Tesfaye BeshirCenter for Materials Engineering, Addis Ababa Institute of Technology, School of Multi-disciplinary Engineering Addis Ababa 1000 Ethiopia georgies.alene@aait.edu.et.
Kingsley O ObodoHySA Infrastructure Centre of Competence, Faculty of Engineering, North-West University, South Africa (NWU) 2531 South Africa.ORCID https://orcid.org/0000-0002-1428-2761
Georgies A AsresCenter for Materials Engineering, Addis Ababa Institute of Technology, School of Multi-disciplinary Engineering Addis Ababa 1000 Ethiopia georgies.alene@aait.edu.et.ORCID https://orcid.org/0000-0003-2584-654X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exotic features of two-dimensional materials have been demonstrated, making them particularly appealing for both photocatalytic and photovoltaic applications. van der Waals corrected density functional theory calculations were performed on AAII-Se MoSSe, AAII-Te MoSTe, and AAII-Se WSSe heterostructures in this study. Our findings reveal that the heterostructures have high stability due to the tiny lattice mismatch and binding energy, which is extremely favorable for epitaxial growth of these heterostructures. According to the electronic band gap calculation, AAII-Se MoSSe and AAII-Se WSSe are semiconducting materials, while AAII-Te MoSTe has metallic properties. Interestingly, all three heterostructures have type II band gap alignment, which is advantageous for photovoltaic and photocatalytic applications. Furthermore, it was discovered that AAII-Se MoSSe and AAII-Se WSSe heterostructures exhibit high power conversion efficiency of up to 12.15% and 9.37%, respectively. Based on these intriguing features, the two heterostructures are excellent prospects for photovoltaic applications. The heterostructures have no appropriate band edge sites for overall water splitting at pH = 0, but they are good for the oxygen evolution process. It is feasible to alter the position of the band edges using strain resulting in improved overall water splitting by the heterostructures.

Identifiers

PMID35530386
PMCPMC9074779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.